RoosterBio and Repligen Collaborate to Advance Scalable Exosome Bioprocessing
Date: 2023-02-09
Repligen Appoints Martin D. Madaus to Board of Directors
Date: 2022-09-19
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement.
Date: 2022-02-15
Repligen Launches AAV Affinity Resins for Gene Therapy Purification
Date: 2021-12-16
Repligen Acquires BioFlex Solutions, LLC
Date: 2021-11-05
Repligen Releases Inaugural Sustainability Report
Date: 2021-09-16
Repligen Announces Agreement to Acquire Avitide Inc
Date: 2021-09-09
Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies
Date: 2021-09-03
Repligen Extends Long Term Supply Agreement with Cytiva for Affinity Ligands
Date: 2021-06-22
Repligen Corporation Announces Agreement to Acquire Polymem S.A.
Date: 2021-02-08
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
Date: 2020-10-27
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
